Creative Planning Has $589,000 Holdings in Innospec Inc. (NASDAQ:IOSP)

Creative Planning boosted its stake in Innospec Inc. (NASDAQ:IOSP) by 4.3% in the second quarter, HoldingsChannel.com reports. The firm owned 4,762 shares of the specialty chemicals company’s stock after buying an additional 195 shares during the period. Creative Planning’s holdings in Innospec were worth $589,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of IOSP. Vanguard Group Inc. increased its stake in shares of Innospec by 5.5% in the first quarter. Vanguard Group Inc. now owns 3,115,167 shares of the specialty chemicals company’s stock valued at $401,670,000 after buying an additional 161,249 shares during the period. Assenagon Asset Management S.A. boosted its holdings in Innospec by 98.4% in the second quarter. Assenagon Asset Management S.A. now owns 120,082 shares of the specialty chemicals company’s stock valued at $14,841,000 after acquiring an additional 59,554 shares during the last quarter. Gendell Jeffrey L acquired a new stake in Innospec during the 1st quarter valued at approximately $7,090,000. Cubist Systematic Strategies LLC raised its holdings in Innospec by 117.3% during the 2nd quarter. Cubist Systematic Strategies LLC now owns 81,311 shares of the specialty chemicals company’s stock worth $10,049,000 after purchasing an additional 43,898 shares during the last quarter. Finally, Marshall Wace LLP acquired a new position in shares of Innospec in the 2nd quarter worth approximately $4,943,000. 96.64% of the stock is owned by institutional investors.

Analyst Ratings Changes

Separately, StockNews.com downgraded shares of Innospec from a “strong-buy” rating to a “buy” rating in a research note on Thursday, August 8th.

Innospec Price Performance

Shares of NASDAQ:IOSP opened at $113.72 on Monday. The business’s 50-day moving average is $110.91 and its 200-day moving average is $120.35. Innospec Inc. has a 1 year low of $95.69 and a 1 year high of $133.71. The company has a market capitalization of $2.84 billion, a price-to-earnings ratio of 19.31 and a beta of 1.07.

Innospec (NASDAQ:IOSP) last announced its quarterly earnings data on Tuesday, August 6th. The specialty chemicals company reported $1.39 EPS for the quarter, topping the consensus estimate of $1.37 by $0.02. Innospec had a net margin of 7.90% and a return on equity of 14.15%. The company had revenue of $435.00 million during the quarter, compared to the consensus estimate of $468.73 million. During the same quarter last year, the firm posted $1.28 EPS. The company’s quarterly revenue was down 9.5% on a year-over-year basis. Analysts anticipate that Innospec Inc. will post 5.95 EPS for the current year.

Insider Buying and Selling at Innospec

In other news, CFO Ian Cleminson sold 3,398 shares of the stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $114.74, for a total transaction of $389,886.52. Following the transaction, the chief financial officer now owns 12,996 shares of the company’s stock, valued at $1,491,161.04. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 1.52% of the company’s stock.

About Innospec

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.